Page last updated: 2024-08-23

bromocriptine and dimethylaminomicheliolide

bromocriptine has been researched along with dimethylaminomicheliolide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, X; Cong, Z; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J1

Other Studies

1 other study(ies) available for bromocriptine and dimethylaminomicheliolide

ArticleYear
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.
    Endocrine-related cancer, 2021, 12-13, Volume: 29, Issue:2

    Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases

2021